Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

Share Price is delayed by 15 minutes
Get Live Data
3179.00    95.00 (3.08%)
Bid:
3186.00
Ask:
3188.00
Spread: 2.00 (0.063%)
Market Cap: £4.43b
CRDA Live PriceLast checked at - London Stock Exchange

Intraday Croda International Share Chart

Acquisition

24 May 2013 07:00

RNS Number : 4809F
Croda International PLC
24 May 2013
 



24 May 2013

 

Croda International Plc

 

Acquisition ofSpecialty Products Business from Arizona Chemical

Naturally derived polyamides expand Croda's broad portfolio of effects

 

Croda International Plc announces today that it has completed the acquisition of the Specialty Products business of Arizona Chemical based in Jacksonville, Florida in the USA. 

 

The acquisition adds a portfolio of class leading oil gelling polymers to Croda's business and further expands its footprint in the polymers arena, while strengthening Croda's leading position in speciality chemicals derived from renewable resources. The technologies and products of the acquired business are naturally derived polyamides with high bio-renewable content, covered by a range of patents.

 

Keith Layden, Croda's Chief Technology Officer, said:

 

"This acquisition represents further progress in our strategy to acquire complementary new technologies. The varied functionality of these specialised polyamides will be a valuable addition to our offerings across both the Consumer Care and Performance Technologies market sectors. In addition, there are a number of opportunities to further differentiate the technology and create value for ourselves and our customers."

 

No manufacturing assets will be acquired as part of this transaction and Croda will immediately commence the relocation of the products to Croda's Mevisa manufacturing site in Spain and when ready, re-launch the products with new trade names and marketing identities.

 

For further information please contact:

 

Keith Layden, Chief Technology Officer Tel: 01405 860 551

Sean Christie, Group Finance Director

 

Charles Armitstead / Rosie Oddy, Pendomer Communications Tel: 020 3603 5224 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQAJMATMBJTBFJ
Date   Source Headline
29th Mar 20227:00 amRNSInvestor seminar
22nd Mar 20226:14 pmRNSAnnual Financial Report
22nd Mar 20224:49 pmRNSDirector/PDMR Shareholding
16th Mar 20225:21 pmRNSDirector/PDMR Shareholding
16th Mar 20225:20 pmRNSDirector/PDMR Shareholding
16th Mar 20225:19 pmRNSDirector/PDMR Shareholding
16th Mar 20225:15 pmRNSDirector/PDMR Shareholding
16th Mar 20225:15 pmRNSDirector/PDMR Shareholding
16th Mar 20225:13 pmRNSDirector/PDMR Shareholding
16th Mar 20225:11 pmRNSDirector/PDMR Shareholding
16th Mar 20225:11 pmRNSDirector/PDMR Shareholding
16th Mar 20225:04 pmRNSDirector/PDMR Shareholding
16th Mar 20225:03 pmRNSDirector/PDMR Shareholding
15th Mar 202211:24 amRNSDirector/PDMR Shareholding
11th Mar 20222:25 pmRNSDirector/PDMR Shareholding
10th Mar 20221:10 pmRNSDirector/PDMR Shareholding
3rd Mar 202211:27 amRNSDirector/PDMR Shareholding
1st Mar 20227:00 amRNSResults for the year ended 31 December 2021
11th Feb 20222:26 pmRNSDirector/PDMR Shareholding
25th Jan 202210:47 amRNSHolding(s) in Company
17th Jan 20222:18 pmRNSHolding(s) in Company
11th Jan 20223:56 pmRNSDirector/PDMR Shareholding
7th Jan 20227:00 amRNSDirectorate Change
6th Jan 20228:41 amRNSDirector Declaration
22nd Dec 20217:36 amRNSAgreement to Sell Majority of PTIC Announcement
13th Dec 20214:23 pmRNSDirector/PDMR Shareholding
22nd Nov 20211:54 pmRNSDirector/PDMR Shareholding
11th Nov 20212:31 pmRNSDirector/PDMR Shareholding
1st Nov 20219:56 amRNSDirector/PDMR Shareholding
1st Nov 20219:52 amRNSDirector/PDMR Shareholding
1st Nov 20219:45 amRNSDirector/PDMR Shareholding
1st Nov 20219:39 amRNSDirector/PDMR Shareholding
1st Nov 20219:37 amRNSDirector/PDMR Shareholding
13th Oct 20212:42 pmRNSDirector/PDMR Shareholding
11th Oct 20215:00 pmRNSDirector/PDMR Shareholding
11th Oct 20212:03 pmRNSDirector/PDMR Shareholding
6th Oct 20212:15 pmRNSDirector/PDMR Shareholding
16th Sep 20215:20 pmRNSDirector/PDMR Shareholding
13th Sep 20212:27 pmRNSDirector/PDMR Shareholding
18th Aug 20217:39 amRNSDirector/PDMR Shareholding
11th Aug 20212:59 pmRNSDirector/PDMR Shareholding
10th Aug 202110:46 amRNSDirector/PDMR Shareholding
4th Aug 202111:49 amRNSDirector/PDMR Shareholding
27th Jul 20217:00 amRNSResults for the six months ended 30 June 2021
23rd Jul 20217:30 amRNSDirectorate Change
13th Jul 20211:58 pmRNSDirector/PDMR Shareholding
9th Jun 20217:39 amRNSDirector Declaration
8th Jun 202110:36 amRNSDirector/PDMR Shareholding
7th Jun 202111:45 amRNSDirector/PDMR Shareholding
4th Jun 20211:13 pmRNSRestatement of results for new reporting structure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.